Please enable JavaScript to continue using this application.

Compare $ALDX vs $APLM | Chartloom

Compare

$ALDX vs $APLM

Aldeyra Therapeutics Inc · Apollomics Inc

ALDX

Aldeyra Therapeutics Inc

APLM

Apollomics Inc

Compare $ALDX vs $APLM

Comparing Aldeyra Therapeutics Inc and Apollomics Inc

ALDXAldeyra Therapeutics Inc

APLMApollomics Inc

ALDXAldeyra Therapeutics Inc

Market cap

$55M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-80.4%

52W performance

-83.7%

FCF yield

-39.9%

APLMApollomics Inc

Market cap

$47M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

11.4%

52W performance

413.1%

FCF yield

-1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALDX

APLM

Detailed metrics comparison

ALDX

Aldeyra Therapeutics Inc

APLM

Apollomics Inc

Market Cap

ALDX$55M

APLM$47M

Enterprise Value

ALDX$10M

APLM$47M

Price

ALDX$0.92

APLM$21.50

P/E Ratio

ALDXN/A

APLMN/A

P/S Ratio

ALDX0.00x

APLM0.00x

EV/Sales

ALDX0.00x

APLM0.00x

EV/EBITDA

ALDX0.00x

APLM0.00x

P/B Ratio

ALDX1.86x

APLM13.94x

P/FCF Ratio

ALDXN/A

APLMN/A

EV/FCF

ALDX-0.46x

APLM-57.95x

PEG Ratio

ALDXN/A

APLMN/A

Forward P/E (NTM)

ALDXN/A

APLMN/A

Forward P/S (NTM)

ALDXN/A

APLMN/A

Revenue (TTM)

ALDX$0

APLM$0

Revenue Growth (YoY)

ALDXN/A

APLMN/A

Forward Rev Growth

ALDX298.2%

APLM0.0%

Gross Margin (TTM)

ALDX0.0%

APLM0.0%

Operating Margin (TTM)

ALDX0.0%

APLM0.0%

EBITDA Margin (TTM)

ALDX0.0%

APLM0.0%

Net Margin (TTM)

ALDX0.0%

APLM0.0%

FCF Margin (TTM)

ALDXN/A

APLMN/A

Net Income (TTM)

ALDX$-23M

APLM$-823K

FCF (TTM)

ALDX$-22M

APLM$-814K

EPS (TTM)

ALDX-$0.38

APLM-$0.06

ROE (TTM)

ALDX-5314.0%

APLM-69339.0%

ROA (TTM)

ALDX-3494.0%

APLM-26328.0%

ROIC (TTM)

ALDX-4205.0%

APLM-56760.0%

Cash

ALDX$45M

APLM$134K

Debt

ALDX$0

APLM$0

Net Cash/Debt

ALDX$45M

APLM$134K

Current Ratio (TTM)

ALDX4.91x

APLM0.96x

Quick Ratio (TTM)

ALDX4.74x

APLM0.88x

Debt/Equity (TTM)

ALDX0.34x

APLM0.20x

Debt/Assets (TTM)

ALDX0.0%

APLM0.0%

Interest Coverage (TTM)

ALDXN/A

APLMN/A

Net Debt/EBITDA (TTM)

ALDX0.00x

APLM0.00x

Beta

ALDX1.21

APLM1.37

52W Performance

ALDX-83.7%

APLM413.1%

YTD Performance

ALDX-80.4%

APLM11.4%

% from 52W High

ALDX-84.5%

APLM-49.0%

% from 52W Low

ALDX6.3%

APLM410.7%

Asset Turnover (TTM)

ALDX0.00x

APLM0.00x

FCF Yield (TTM)

ALDX-39.9%

APLM-1.7%

Earnings Yield (TTM)

ALDX-41.7%

APLM-1.7%

Dividend Yield (TTM)

ALDXN/A

APLMN/A

Rule of 40

ALDX0.0

APLM0.0

EV/GP/RG

ALDXN/A

APLMN/A

Ticker research

View ALDX research View APLM research

Metric	ALDX Aldeyra Therapeutics Inc	APLM Apollomics Inc
Market & Valuation
Market Cap	$55M	$47M
Enterprise Value	$10M	$47M
Price	$0.92	$21.50
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.86x	13.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-57.95x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	298.2%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-23M	$-823K
FCF (TTM)	$-22M	$-814K
EPS (TTM)	-$0.38	-$0.06
ROE (TTM)	-5314.0%	-69339.0%
ROA (TTM)	-3494.0%	-26328.0%
ROIC (TTM)	-4205.0%	-56760.0%
Financial Health
Cash	$45M	$134K
Debt	$0	$0
Net Cash/Debt	$45M	$134K
Current Ratio (TTM)	4.91x	0.96x
Quick Ratio (TTM)	4.74x	0.88x
Debt/Equity (TTM)	0.34x	0.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	1.37
52W Performance	-83.7%	413.1%
YTD Performance	-80.4%	11.4%
% from 52W High	-84.5%	-49.0%
% from 52W Low	6.3%	410.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-39.9%	-1.7%
Earnings Yield (TTM)	-41.7%	-1.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALDX research	View APLM research

Valuation

P/S Ratio

ALDX

0.00x

APLM

0.00x

EV/FCF

APLM

-57.95x

ALDX

-0.46x

Growth & revenue

Forward Revenue Growth

ALDX

298.2%

APLM

0.0%

Profitability & performance

Gross Margin

ALDX

0.0%

APLM

0.0%

ROE

ALDX

-5314.0%

APLM

-69339.0%

FCF Yield %

APLM

-1.7%

ALDX

-39.9%

52-Week Performance

APLM

413.1%

ALDX

-83.7%

Detailed metrics comparison

ALDX

Aldeyra Therapeutics Inc

APLM

Apollomics Inc

Market Cap

ALDX$55M

APLM$47M

Enterprise Value

ALDX$10M

APLM$47M

Price

ALDX$0.92

APLM$21.50

P/E Ratio

ALDXN/A

APLMN/A

P/S Ratio

ALDX0.00x

APLM0.00x

EV/Sales

ALDX0.00x

APLM0.00x

EV/EBITDA

ALDX0.00x

APLM0.00x

P/B Ratio

ALDX1.86x

APLM13.94x

P/FCF Ratio

ALDXN/A

APLMN/A

EV/FCF

ALDX-0.46x

APLM-57.95x

PEG Ratio

ALDXN/A

APLMN/A

Forward P/E (NTM)

ALDXN/A

APLMN/A

Forward P/S (NTM)

ALDXN/A

APLMN/A

Revenue (TTM)

ALDX$0

APLM$0

Revenue Growth (YoY)

ALDXN/A

APLMN/A

Forward Rev Growth

ALDX298.2%

APLM0.0%

Gross Margin (TTM)

ALDX0.0%

APLM0.0%

Operating Margin (TTM)

ALDX0.0%

APLM0.0%

EBITDA Margin (TTM)

ALDX0.0%

APLM0.0%

Net Margin (TTM)

ALDX0.0%

APLM0.0%

FCF Margin (TTM)

ALDXN/A

APLMN/A

Net Income (TTM)

ALDX$-23M

APLM$-823K

FCF (TTM)

ALDX$-22M

APLM$-814K

EPS (TTM)

ALDX-$0.38

APLM-$0.06

ROE (TTM)

ALDX-5314.0%

APLM-69339.0%

ROA (TTM)

ALDX-3494.0%

APLM-26328.0%

ROIC (TTM)

ALDX-4205.0%

APLM-56760.0%

Cash

ALDX$45M

APLM$134K

Debt

ALDX$0

APLM$0

Net Cash/Debt

ALDX$45M

APLM$134K

Current Ratio (TTM)

ALDX4.91x

APLM0.96x

Quick Ratio (TTM)

ALDX4.74x

APLM0.88x

Debt/Equity (TTM)

ALDX0.34x

APLM0.20x

Debt/Assets (TTM)

ALDX0.0%

APLM0.0%

Interest Coverage (TTM)

ALDXN/A

APLMN/A

Net Debt/EBITDA (TTM)

ALDX0.00x

APLM0.00x

Beta

ALDX1.21

APLM1.37

52W Performance

ALDX-83.7%

APLM413.1%

YTD Performance

ALDX-80.4%

APLM11.4%

% from 52W High

ALDX-84.5%

APLM-49.0%

% from 52W Low

ALDX6.3%

APLM410.7%

Asset Turnover (TTM)

ALDX0.00x

APLM0.00x

FCF Yield (TTM)

ALDX-39.9%

APLM-1.7%

Earnings Yield (TTM)

ALDX-41.7%

APLM-1.7%

Dividend Yield (TTM)

ALDXN/A

APLMN/A

Rule of 40

ALDX0.0

APLM0.0

EV/GP/RG

ALDXN/A

APLMN/A

Ticker research

View ALDX research View APLM research

Metric	ALDX Aldeyra Therapeutics Inc	APLM Apollomics Inc
Market & Valuation
Market Cap	$55M	$47M
Enterprise Value	$10M	$47M
Price	$0.92	$21.50
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.86x	13.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-57.95x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	298.2%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-23M	$-823K
FCF (TTM)	$-22M	$-814K
EPS (TTM)	-$0.38	-$0.06
ROE (TTM)	-5314.0%	-69339.0%
ROA (TTM)	-3494.0%	-26328.0%
ROIC (TTM)	-4205.0%	-56760.0%
Financial Health
Cash	$45M	$134K
Debt	$0	$0
Net Cash/Debt	$45M	$134K
Current Ratio (TTM)	4.91x	0.96x
Quick Ratio (TTM)	4.74x	0.88x
Debt/Equity (TTM)	0.34x	0.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	1.37
52W Performance	-83.7%	413.1%
YTD Performance	-80.4%	11.4%
% from 52W High	-84.5%	-49.0%
% from 52W Low	6.3%	410.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-39.9%	-1.7%
Earnings Yield (TTM)	-41.7%	-1.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALDX research	View APLM research